REDUCTION OF LDL CHOLESTEROL BY PRAVASTATIN DOES NOT INFLUENCE PLATELET ACTIVATION IN PATIENTS WITH MILD HYPERCHOLESTEROLEMIA AT RISK OF CORONARY HEART-DISEASE

被引：17
|
作者：
BARROW, SE [1 ]
STRATTON, PD [1 ]
BENJAMIN, N [1 ]
BRASSFIELD, T [1 ]
RITTER, JM [1 ]
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT,CLIN RES DEPT,HOUNSLOW TW3 3JA,MIDDX,ENGLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1991年 / 32卷 / 01期
关键词：
THROMBOXANE A2; PLATELET ACTIVATION; PRAVASTATIN; LDL; HYPERCHOLESTEROLEMIA;
D O I：
10.1111/j.1365-2125.1991.tb05625.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effect of pravastatin on low density lipoprotein (LDL) cholesterol and platelet activation was studied in 16 patients with mild hypercholesterolaemia who had two or more additional cardiovascular risk factors. Patients were treated with either pravastatin (20-40 mg day-1) or placebo for 1 year. Plasma LDL and urinary excretion of 2,3-dinor-thromboxane B2 (an index of platelet activation in vivo) were determined at 0, 3, 6 and 12 months. There was a significant reduction in LDL at 6 and 12 months (2P < 0.05) but this was not associated with any significant change in thromboxane metabolite excretion.
引用
收藏
页码：127 / 129
页数：3
相关论文
共 50 条
  • [41] RISK PROFILE OF PATIENTS WITH CORONARY HEART-DISEASE
    BILGIN, Y
    ARAT, A
    KARATAY, E
    ORDUHAN, A
    SEN, C
    BRENNER, G
    DOPPL, W
    KLOR, HU
    BECKMANN, D
    MEDIZINISCHE WELT, 1994, 45 (04): : 136 - 139
  • [42] CHOLESTEROL REDUCTION IN THE PREVENTION OF CORONARY HEART-DISEASE - THERAPEUTIC RATIONALE AND GUIDELINES
    COBBE, SM
    SHEPHERD, J
    BRITISH HEART JOURNAL, 1993, 69 (01): : S63 - S69
  • [43] REDUCTION IN SERUM-CHOLESTEROL WITH PRAVASTATIN IMPROVES ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    EGASHIRA, K
    HIROOKA, Y
    KAI, H
    SUGIMACHI, M
    SUZUKI, S
    INOU, T
    TAKESHITA, A
    CIRCULATION, 1994, 89 (06) : 2519 - 2524
  • [44] EFFECTS OF GEMFIBROZIL ON LDL METABOLISM IN HYPERTRIGLYCERIDEMIC PATIENTS WITH CORONARY HEART-DISEASE
    VEGA, GL
    GRUNDY, SM
    ARTERIOSCLEROSIS, 1984, 4 (05): : A548 - A548
  • [45] JOINT EFFECTS OF SERUM TRIGLYCERIDE AND LDL CHOLESTEROL AND HDL CHOLESTEROL CONCENTRATIONS ON CORONARY HEART-DISEASE RISK IN THE HELSINKI HEART-STUDY - IMPLICATIONS FOR TREATMENT
    MANNINEN, V
    TENKANEN, L
    KOSKINEN, P
    HUTTUNEN, JK
    MANTTARI, M
    HEINONEN, OP
    FRICK, MH
    CIRCULATION, 1992, 85 (01) : 37 - 45
  • [46] CIRCULATING PLATELET AGGREGATES IN CARDIAC PATIENTS WITH CORONARY HEART-DISEASE
    POPADIC, M
    REZAKOVIC, D
    GRINFELD, B
    HAEMOSTASIS, 1982, 12 (1-2) : 128 - 128
  • [47] INFLUENCE OF REDUCTION OF SERUM LIPIDS ON PROGNOSIS OF CORONARY HEART-DISEASE
    TODD, JW
    OLIVER, MF
    BOYD, GS
    LANCET, 1961, 2 (720): : 775 - &
  • [48] Role of Aggressive LDL Reduction in Patients With Coronary Heart Disease
    Benge, Cassandra D.
    Markley, Brandon
    McFarland, Michael Shawn
    SOUTHERN MEDICAL JOURNAL, 2012, 105 (01) : 48 - 55
  • [49] THE EFFECTS OF LOWERING SERUM-CHOLESTEROL ON CORONARY HEART-DISEASE RISK
    ROSSOUW, JE
    MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (01) : 181 - 195
  • [50] REDUCTION OF CORONARY HEART-DISEASE RISK - A COMPARISON OF DIETARY RECOMMENDATIONS
    LEWIS, B
    PROGRESS IN LIPID RESEARCH, 1986, 25 : 451 - 453
12345